The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of intravaginal 17-β estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors.
Shari Beth Goldfarb
No relevant relationships to disclose
Maura N. Dickler
No relevant relationships to disclose
Ann M. Dnistrian
No relevant relationships to disclose
Sujata Patil
No relevant relationships to disclose
Lara Dunn
No relevant relationships to disclose
Kaity Chang
No relevant relationships to disclose
Alyssa Peri Berkowitz
No relevant relationships to disclose
Noah Tucker
No relevant relationships to disclose
Jeanne Carter
No relevant relationships to disclose
Richard R. Barakat
No relevant relationships to disclose
Clifford Hudis
Research Funding - Merck
Other Remuneration - Estee Lauder Company (I)
Mercedes Castiel
No relevant relationships to disclose